Efanesoctocog Alfa Treatment ' Victory ' for Hemophilia A Patients Efanesoctocog Alfa Treatment ' Victory ' for Hemophilia A Patients

A once-weekly prophylactic treatment of this investigational agent led to normal or near-normal factor VIII activity levels in most patients with severe hemophilia A.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news